Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Avid Bioservices Inc (CDMO)  
$9.09 0.01 (0.11%) as of 4:30 Wed 5/22


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 69,174,000
Market Cap: 628.79(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.64 - $17.21
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 9.2
Insider 3/6 Months : 9.8
Guru Rank Number :  574
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Avid Bioservices is a contract development and manufacturing organization that provides a range of services from process development to Current Good Manufacturing Practices (CGMP) clinical and commercial manufacturing, focused on biopharmaceutical drug substances derived from mammalian cell culture. Co. produces monoclonal antibodies and recombinant proteins, and its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. Co. also provides process development services, including upstream and downstream development, analytical method development, testing and characterization.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 61,803 81,803 81,803
Total Buy Value $0 $336,770 $527,466 $527,466
Total People Bought 0 1 2 2
Total Buy Transactions 0 2 3 3
Total Shares Sold 18,578 24,837 136,703 332,920
Total Sell Value $137,460 $176,242 $1,628,455 $5,111,613
Total People Sold 5 5 6 8
Total Sell Transactions 6 12 38 69
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 417
  Page 12 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Lytle Paul J Chief Financial Officer   •       –      –    2017-04-28 4 A $0.27 $10,140 D/D 37,389 184,038     -
   Shan Joseph VP, Clinical and Reg Affairs   •       –      –    2017-04-28 4 A $0.27 $10,625 D/D 39,177 94,079     -
   Shan Joseph VP, Clinical and Reg Affairs   •       –      –    2016-10-31 4 A $0.29 $9,675 D/D 33,783 54,902     -
   Lytle Paul J Chief Financial Officer   •       –      –    2016-10-31 4 A $0.29 $9,675 D/D 33,783 146,649     -
   King Steven W President & CEO   •       •      –    2016-10-31 4 A $0.29 $5,392 D/D 18,826 212,789     -
   Fussey Shelley Pm V.P., Intellectual Property   •       –      –    2016-10-31 4 A $0.29 $7,284 D/D 25,433 135,908     -
   Shan Joseph VP, Clinical and Reg Affairs   •       –      –    2016-04-29 4 A $0.30 $3,216 D/D 10,683 21,119     -
   King Steven W President & CEO   •       •      –    2016-04-29 4 A $0.30 $3,216 D/D 10,683 193,963     -
   Fussey Shelley Pm V.P., Intellectual Property   •       –      –    2016-04-29 4 A $0.30 $3,216 D/D 10,683 110,475     -
   Fussey Shelley Pm V.P., Intellectual Property   •       –      –    2015-10-30 4 A $0.95 $8,026 D/D 8,448 99,792     -
   Dart Kenneth Bryan 10% Owner   –       –       •   2015-10-30 3 IO $0.00 $0 D/D 0 26,440,278     -
   Lytle Paul J Chief Financial Officer   •       –      –    2015-10-30 4 A $0.95 $5,850 D/D 6,158 112,866     -
   King Steven W President & CEO   •       •      –    2015-10-30 4 A $0.95 $5,200 D/D 5,474 183,280     -
   Lytle Paul J Chief Financial Officer   •       –      –    2015-04-30 4 A $1.11 $5,791 D/D 5,217 106,708     -
   King Steven W President & CEO   •       •      –    2015-04-30 4 A $1.11 $5,144 D/D 4,634 177,806     -
   Fussey Shelley Pm V.P., Intellectual Property   •       –      –    2015-04-30 4 A $1.11 $7,969 D/D 7,179 91,344     -
   King Steven W President & CEO   •       •      –    2014-04-30 4 A $1.11 $4,462 D/D 4,020 169,892     -
   Fussey Shelley Pm V.P., Intellectual Property   •       –      –    2014-04-30 4 A $1.11 $7,294 D/D 6,571 78,803     -
   King Steven W President & CEO   •       •      –    2014-04-29 4 D $0.00 $0 D/D (25,662) 165,872     -
   King Steven W President & CEO   •       •      –    2013-10-31 4 A $1.08 $4,461 D/D 4,131 191,534     -
   Fussey Shelley Pm V.P., Intellectual Property   •       –      –    2013-10-31 4 A $1.08 $7,292 D/D 6,752 72,232     -
   King Steven W President & CEO   •       •      –    2013-10-15 4 A $0.00 $0 D/D 100,000 187,403     -
   King Steven W President & CEO   •       •      –    2013-04-30 4 A $0.71 $4,626 D/D 6,516 87,403     -
   Fussey Shelley Pm V.P., Intellectual Property   •       –      –    2013-04-30 4 A $0.71 $7,442 D/D 10,481 65,480     -
   Lytle Paul J Chief Financial Officer   •       –      –    2013-04-30 4 A $0.71 $8,511 D/D 11,988 101,491     -

  417 Records found
  Previous  10  11  12  13  14  15  16  17   
  Page 12 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed